Investments AbbVie Invests $223m in Singapore to Expand Biologics Manufacturing CapacityBy Asia Business HeadlinesJanuary 26, 20240 New York-listed AbbVie strengthened its manufacturing capabilities by breaking ground on a new $223 million expansion of its Singapore manufacturing…
